1. Home
  2. TTGT vs SIGA Comparison

TTGT vs SIGA Comparison

Compare TTGT & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechTarget Inc.

TTGT

TechTarget Inc.

HOLD

Current Price

$4.65

Market Cap

416.4M

ML Signal

HOLD

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

HOLD

Current Price

$4.67

Market Cap

341.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTGT
SIGA
Founded
1999
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
416.4M
341.0M
IPO Year
2024
2016

Fundamental Metrics

Financial Performance
Metric
TTGT
SIGA
Price
$4.65
$4.67
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$10.75
N/A
AVG Volume (30 Days)
603.6K
497.5K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
13.24%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.45
N/A
Revenue Next Year
$2.75
$224.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.41
$4.10
52 Week High
$9.00
$9.62

Technical Indicators

Market Signals
Indicator
TTGT
SIGA
Relative Strength Index (RSI) 44.14 52.53
Support Level $3.52 $4.29
Resistance Level $4.75 $4.86
Average True Range (ATR) 0.47 0.19
MACD -0.12 0.05
Stochastic Oscillator 9.19 71.52

Price Performance

Historical Comparison
TTGT
SIGA

About TTGT TechTarget Inc.

TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. The company provides marketing and sales services that deliver business impact for enterprise technology companies. It develops editorial content across multiple technology-focused websites and channels to engage audiences researching information technology solutions. The company generates revenue by providing market insight and market access to the technology market, including enterprise technology, artificial intelligence, channel, cybersecurity, media & entertainment, and service providers. Geographically, it derives the majority of revenue from North America.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

Share on Social Networks: